AJANTPHARM — Ajanta Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹276.20bn
- IN₹271.71bn
- IN₹37.43bn
- 99
- 13
- 97
- 85
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,599 | 2,695 | 3,782 | 3,282 | 8,401 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,619 | 8,313 | 8,358 | 10,825 | 11,251 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 11,812 | 16,417 | 20,276 | 22,645 | 28,252 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 14,332 | 15,829 | 16,296 | 16,474 | 16,982 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 26,962 | 33,187 | 37,787 | 40,556 | 46,790 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,776 | 6,062 | 6,486 | 6,474 | 11,393 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,510 | 7,198 | 7,831 | 7,912 | 12,910 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 22,452 | 25,989 | 29,956 | 32,643 | 33,880 |
Total Liabilities & Shareholders' Equity | 26,962 | 33,187 | 37,787 | 40,556 | 46,790 |
Total Common Shares Outstanding |